HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dirk-Uwe Bartsch Selected Research

Dirk-Uwe Bartsch Research Topics

Disease

11Macular Degeneration (Age-Related Maculopathy)
01/2023 - 01/2003
5Epiretinal Membrane (Epiretinal Membranes)
07/2019 - 01/2008
5Macular Edema
08/2014 - 01/2008
4Retinitis
01/2015 - 02/2006
4Choroidal Neovascularization
05/2014 - 01/2003
3Ganglion Cysts (Ganglion)
11/2018 - 12/2009
2Infections
01/2023 - 11/2011
2Diabetic Retinopathy (Retinopathy, Diabetic)
10/2019 - 05/2013
2Retinitis Pigmentosa (Pigmentary Retinopathy)
09/2019 - 01/2019
2Edema (Dropsy)
01/2019 - 03/2010
2Retinal Degeneration
01/2019 - 12/2018
2Melanoma (Melanoma, Malignant)
04/2018 - 09/2002
2Late-Onset Retinal Degeneration
01/2015 - 05/2011
2Cysts
03/2010 - 01/2008
1COVID-19
01/2023
1Pain (Aches)
06/2021
1Retinal Hemorrhage
07/2019
1Hyperopia (Hypermetropia)
01/2019
1Optic Disk Drusen (Optic Disc Drusen)
01/2019
1Microphthalmos
01/2019
1Atrophy
01/2019
1Nevus (Nevi)
04/2018
1Hypertrophy
04/2018
1Papilledema
01/2015
1Necrosis
01/2015
1Vision Disorders (Hemeralopia)
01/2014
1Hemorrhage
01/2013
1Choroid Diseases
12/2012
1Inflammation (Inflammations)
08/2012
1Microaneurysm
05/2012
1Wounds and Injuries (Trauma)
01/2010
1Retinal Perforations
01/2008
1HIV Infections (HIV Infection)
09/2006
1Gliosis
04/2006
1Uveitis
02/2006
1Cytomegalovirus Retinitis
02/2005
1Uveal melanoma
09/2002
1Neoplasms (Cancer)
09/2002
1Retinal Diseases
01/2002
1Retinal Neovascularization
01/2002
1Hyperoxia
01/2002
1Hypoxia (Hypoxemia)
01/2002

Drug/Important Bio-Agent (IBA)

25Retinaldehyde (Retinal)IBA
01/2023 - 02/2005
6Fluorescein (Funduscein)FDA LinkGeneric
08/2014 - 01/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 09/2015
2Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2021
2Proteins (Proteins, Gene)FDA Link
01/2015 - 05/2011
2prinomastat (Ag3340)IBA
06/2004 - 01/2002
1proxymetacaine (Alcaine)FDA LinkGeneric
06/2021
1Lidocaine (Xylocaine)FDA LinkGeneric
06/2021
1Retinal Pigments (Pigments, Visual)IBA
01/2019
1Bevacizumab (Avastin)FDA Link
09/2015
1Endothelial Growth FactorsIBA
09/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
08/2012
11-penicillamyl-Leu(2)- oxytocinIBA
08/2012
1Complement Factor H (Factor H)IBA
08/2012
1hexadecyloxypropyl- arabinofuranosylguanine 5'-monophosphateIBA
01/2010
1hexadecyloxypropyl 5-fluoro-2'-deoxyuridine cyclic-3',5'-monophosphateIBA
01/2010
1ImmunosorbentsIBA
02/2006
1CytokinesIBA
02/2006
1Interleukin-6 (Interleukin 6)IBA
02/2006
1Interleukin-12 (IL 12)IBA
02/2006
1EnzymesIBA
02/2006
1DNA (Deoxyribonucleic Acid)IBA
02/2006
1Interferon-gamma (Interferon, gamma)IBA
02/2006
1Matrix Metalloproteinase InhibitorsIBA
06/2004
1Peptides (Polypeptides)IBA
02/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2004
1SuspensionsIBA
09/2002
1Oxygen (Dioxygen)IBA
01/2002
1Metalloproteases (Metalloproteinases)IBA
01/2002

Therapy/Procedure

8Lasers (Laser)
07/2019 - 09/2002
3Therapeutics
09/2015 - 05/2011
2Vitrectomy
04/2021 - 01/2008
1Prostheses and Implants (Prosthesis)
09/2019
1Visual Prosthesis
12/2018
1Light Coagulation
08/2014
1Traction
05/2014
1Semiconductor Lasers
06/2004
1Intraperitoneal Injections
01/2002